Search research articles
Contact Us
Filters
Showing results (21-30 of 189) with videos related to
Page
of 19
Sort By:
British Medical Journal
|
April 1, 1978
Haemodialysis during cyclophosphamide treatment
R A Milsted, M Jarman
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Metabolism of high doses of cyclophosphamide
R A Milsted, M Jarman
British Medical Journal
|
August 25, 1979
Alcoholism in the general hospital
C M Jarman, J M Kellett
The International Journal of Behavioral Nutrition and Physical Activity
|
February 23, 2022
Influences on the dietary intakes of preschool children: a systematic scoping review
M Jarman, K Edwards, J Blissett
Carcinogenesis
|
March 1, 1994
A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism
G A Potter, R McCague, M Jarman
Biochemical Pharmacology
|
September 1, 1973
Steric hindrance to hydroxyl-group assisted acyl group migration in 2'-(3')-O-acylribonucleosides: a reassessment correction
J Baker, M Jarman, J A Stock
Chemico-Biological Interactions
|
March 1, 1978
Metabolism of N-nitrosomorpholine by the rat in vivo and by rat liver microsomes and its oxidation by the Fenton system
D Manson, P J Cox, M Jarman
Journal of the Chemical Society. Perkin Transactions 1
|
January 1, 1973
Synthesis of 2'- and 3'-O-acyluridines
J Baker, M Jarman, J A Stock
The International Journal of Oral & Maxillofacial Implants
|
March 16, 2017
Comparing the Fracture Resistance of Alternatively Engineered Zirconia Abutments with Original Equipment Manufactured Abutments with Different Implant Connection Designs
Joseph M Jarman, Techkouhie Hamalian, Anthony P Randi
Journal of Medicinal Chemistry
|
January 6, 1999
The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors
M Jarman, S E Barrie, J M Llera
Page
of 19
Search research articles
Search
Showing results (21-30 of 189) with videos related to
Sort By:
Page
of 19
British Medical Journal
|
April 1, 1978
Haemodialysis during cyclophosphamide treatment
R A Milsted, M Jarman
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Metabolism of high doses of cyclophosphamide
R A Milsted, M Jarman
British Medical Journal
|
August 25, 1979
Alcoholism in the general hospital
C M Jarman, J M Kellett
The International Journal of Behavioral Nutrition and Physical Activity
|
February 23, 2022
Influences on the dietary intakes of preschool children: a systematic scoping review
M Jarman, K Edwards, J Blissett
Carcinogenesis
|
March 1, 1994
A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism
G A Potter, R McCague, M Jarman
Biochemical Pharmacology
|
September 1, 1973
Steric hindrance to hydroxyl-group assisted acyl group migration in 2'-(3')-O-acylribonucleosides: a reassessment correction
J Baker, M Jarman, J A Stock
Chemico-Biological Interactions
|
March 1, 1978
Metabolism of N-nitrosomorpholine by the rat in vivo and by rat liver microsomes and its oxidation by the Fenton system
D Manson, P J Cox, M Jarman
Journal of the Chemical Society. Perkin Transactions 1
|
January 1, 1973
Synthesis of 2'- and 3'-O-acyluridines
J Baker, M Jarman, J A Stock
The International Journal of Oral & Maxillofacial Implants
|
March 16, 2017
Comparing the Fracture Resistance of Alternatively Engineered Zirconia Abutments with Original Equipment Manufactured Abutments with Different Implant Connection Designs
Joseph M Jarman, Techkouhie Hamalian, Anthony P Randi
Journal of Medicinal Chemistry
|
January 6, 1999
The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors
M Jarman, S E Barrie, J M Llera
Page
of 19